Announcement of EMEA Authorisation of Celgene's VIDAZA (Azacitidine) for Treatment of MDS and AML
LONDON, March 2 /PRNewswire/ -- The granting by EMEA of full marketing authorisation for Celgene's VIDAZA will bring new hope to MDS patients, particularly those with high risk forms of these…